Unknown

Dataset Information

0

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.


ABSTRACT: Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the ParsortixTM system, micromanipulation with CellCelectorTM and subsequent single cell multi-marker transcriptome profiling. First, a PCR panel consisting of 30 different endocrine resistance and phenotypic marker genes was validated for single cell profiling by using different breast cancer cell lines. Second, this panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy. Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs' differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). Moreover, ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping. Our findings demonstrate that multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance.

SUBMITTER: Reinhardt F 

PROVIDER: S-EPMC6679140 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.

Reinhardt Florian F   Franken André A   Meier-Stiegen Franziska F   Driemel Christiane C   Stoecklein Nikolas H NH   Fischer Johannes C JC   Niederacher Dieter D   Ruckhaeberle Eugen E   Fehm Tanja T   Neubauer Hans H  

Cancers 20190628 7


Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the Parsortix<sup>TM</sup> system, micromanipulation with CellCelector<sup>TM</sup> and subsequent single  ...[more]

Similar Datasets

| S-EPMC3799344 | biostudies-literature
| S-EPMC8351364 | biostudies-literature
| S-EPMC5193022 | biostudies-literature
| S-EPMC9679687 | biostudies-literature
| S-EPMC4732889 | biostudies-literature
2024-02-29 | GSE255775 | GEO
2011-08-16 | E-GEOD-31411 | biostudies-arrayexpress
| S-EPMC7762778 | biostudies-literature
2024-02-29 | GSE260560 | GEO
2024-02-29 | GSE259422 | GEO